ImpediMed (ASX:IPD) Edges Up on ASX on Acquiring HITRUST Certification


  • ImpediMed Limited (ASX:IPD) has secured the Health Information Trust Alliance Certification (HITRUST).
  • HITRUST sets the global standard for safeguarding information.
  • ImpediMed’s goal is to make continuous improvements in safeguarding customer and patient data via its cloud-based technology.

Medical technology company ImpediMed Limited (ASX:IPD) believes in a strong commitment to confidentiality, integrity, and availability of its customers’ data. In alignment with this, ImpediMed has achieved HITRUST Certification, joining the select group of companies to pass the rigorous certification process.

“HITRUST is the benchmark for certification, providing our customers and their patients assurance their data is secure”, says Managing Director and CEO Mr Richard Carreon. He further added that the Company is very pleased with this outcome.

Notably, the significant market update set the IPD shares soar higher, and it was trading up by 8 per cent at $ 0.135, mid-day on 18 December 2020.

Significance of HITRUST Certification

ImpediMed has sought a risk management framework which encompasses the belief of adhering to confidentiality, integrity, and availability of its customers’ data. After a comprehensive process, it has finally achieved HITRUST Certification.

The grant places this strong Company firmly rooted in digital healthcare space, at the forefront of quality assurance and customer data protection. Besides, the certification gives the highest level of assurance in the Company’s systems integrity.

Further, Mr Richard Carreon approves the thought process that the HITRUST Certification will further streamline the Company’s sales process with major institutions beginning to require HITRUST as a prerequisite to conducting business.

Also read about ImpediMed’s & NSW Health Partnership Update HERE

HITRUST- An Overview

HITRUST stands for the Health Information Trust Alliance. It was founded to help organisations effectively manage data, information risk and compliance. It further enables vendors and covered entities to display compliance to HIPAA obligations based on a standardised security framework.

ImpediMed’s HITRUST Certification Process

HITRUST certification process is a comprehensive assessment of the Company’s risk, privacy and security of its policies, procedures, and controls. For the validated assessment, ImpediMed implemented additional privacy and security controls to accomplish compliance with the 19 Domains of HITRUST that include:

  • Information Protection Programs
  • Endpoint Protection
  • Configuration Management
  • Business Continuity and Disaster Recovery
  • Education Training Awareness
  • Data Protection

Did you know ImpediMed recently signed a second contract with AstraZeneca? CLICK HERE to know more.

Way Forward

ImpediMed remains focused on three key areas of growth: Oncology, Heart Failure and Renal Failure. ImpediMed has transformed into a contemporary medical technology company, charting out remarkable success story during the pandemic.

Notably, ImpediMed’s breakthrough SOZO® technology is being adopted within the medical community at a rapid pace.





Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK